Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Innovation Grade Ventures (IGV) is a venture creation firm that builds life science companies around high-quality, 'innovation grade' intellectual property. The firm specializes in identifying and licensing foundational technologies from academic institutions and research centers to form the basis of new biotechnology startups. IGV provides strategic leadership, intellectual property expertise, and operational support to de-risk early-stage assets and prepare them for institutional financing. By focusing on rigorous IP validation and clinical potential, the company aims to accelerate the translation of breakthrough science into transformative therapies. Their portfolio includes companies focused on diverse modalities such as gene therapy, protein engineering, and oncology therapeutics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Innovation Grade Ventures.